School of nanomedicine and cancer immunotherapy – 24th-25th October 2023

Melomanes Fall School

We are happy to announce our School of nanomedicine and cancer immunotherapy. It will take place on Tuesday 24th and Wednesday 25th October 2023, at Åbo Akademi University in Turku (Finland).

Our Melomanes researchers, together with invited local partners, will provide an overview of their multidisciplinary cutting-edge research. Discover how nanomedicine and novel immunotherapies are opening new roads for cancer treatments!

This event is aimed at early-stage researchers interested in getting a broad overview of these fields of research.
It is open to researchers outside Melomanes network.

Registration

Registration fees: 100€ for the 2-day school (refreshments and buffet lunch included)
Register here by Tuesday 10 October (extended deadline).

The school will be followed by a free workshop on career development beyond academia on Thursday 26th October, in Joki, BioCity, Turku.

Speakers

• Dr. Yassen Abbas, CN Bio (United Kingdom): Development of organ-on-chip for the investigation of cancer treatments
• Prof. Khuloud Al-Jamal, King’s College London (United Kingdom): Therapeutic and diagnosis applications of nanomaterials
• Dr. Belén Ballesteros, Institut Català de Nanociència i Nanotecnologia (Spain): Advanced electron microscopy techniques for nanoscience
• Prof. Davide Bonifazi, University of Vienna (Austria): Functional organic architectures for nanomedicine
• Dr. Emmanuel Donnadieu, Institut Cochin (France): Predicting safety and efficacy of engineered T cells using an ex vivo human model
• Dr. Lorena García Hevia, IDIVAL (Spain): In vitro and in vivo models to evaluate nanomaterials for cancer treatment
• Dr. Florence Gazeau, CNRS MSC Med (France): Magnetic hyperthermia and photothermal treatments in nanomedicine
• Prof. Roland Grafström, Karolinska Institutet (Sweden): Assessment of cellular mode-of-actions by toxicogenomics space modeling
• Dr. Roland Hischier, Empa (Switzerland): Life cycle assessment in nanomedicine
• Dr. Jianwei Li, University of Turku (Finland): Molecular systems engineering for nanomedicine
• Dr. Sammeli Liikkanen, Orion Pharma (Finland): Data and AI driven drug research and development
• Dr. Cécilia Ménard-Moyon, CNRS I2CT (France): Multifunctionalisation of nanoparticles for nanomedicine
• Dr. Michiel van Oudheusden, Vrije Universiteit Amsterdam (Netherlands): Responsible modulation of nanotechnologies: examples and pathways
  
• Dr. Raphaël Rodriguez, Institut Curie (France): Chemical control of cell plasticity
• Prof. Jessica Rosenholm, Åbo Akademi University (Finland): Multifunctional hybrid and composite nanostructures for drug delivery and imaging
• Dr. Gerard Tobías-Rossell, Institut de Ciència de Materials de Barcelona (Spain): Radioactive nanomaterials for the diagnosis and treatment of cancer
• Dr. Sébastien Wälchli, Oslo University Hospital (Norway): New perspectives of engineered T-cells in cancer therapy

The talk titles are provisional. The school agenda will be provided by early October.